Myeloid Panel Analysis Imperative for Risk Assessment in Pat

A myeloid panel mutation analysis should be prioritized for patients with clonal cytopenia of undetermined significance (CCUS) as it can better assess patient risks for progression to a myeloid malignancy, a recent study argues.

Related Keywords

United Kingdom , , Haematological Malignancy Diagnostic Service In Leeds , Mutation Concept , Haematological Malignancy Diagnostic Service , Rare Blood , Cytopenia , Clonal Cytopenia , Idiopathic Cytopenia , Ccus , Icus , Myeloid Panel , Agenetic Mutation , Blood Mutation , Myeloid Malignancy ,